The efficacy of nicotine patches among pregnant smokers was investigated using a randomised placebo controlled trial. The intervention was the administration of 16 hour nicotine patches after recruitment until the time of delivery. Participants were pregnant women over 18 years who smoked at least five cigarettes a day and whose babies were between 12 and 20 weeks’ gestation. In total, 402 women were recruited from 23 maternity wards throughout France and randomly allocated to the intervention (n=203) or placebo patches (n=199).1 The outcome measures included achievement of complete abstinence until delivery and birth weight. The proportion of women who achieved complete abstinence was higher in the nicotine patch group than in the placebo group, although the difference was not significant (11 (5.5%) v 10 (5.1%); odds ratio 1.08, 95% confidence interval 0.45 to 2.60; P=0.87). The mean birth weight was higher in the nicotine patch group, although the difference was not significant (3065 g (standard error 44 g) v 3015 g (44 g); difference 50 g, −71.1 to 172.3; P=0.41). It was concluded that the nicotine patch did not increase smoking cessation rates or birth weights when compared with placebo. Which of the following statements, if any, are true?
No takes yet. Share an insight, caveat, or question.
P. Sedgwick (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: